Asako Murayama

1.9k total citations
50 papers, 1.6k citations indexed

About

Asako Murayama is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Asako Murayama has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 38 papers in Hepatology and 7 papers in Molecular Biology. Recurrent topics in Asako Murayama's work include Hepatitis C virus research (38 papers), Hepatitis B Virus Studies (37 papers) and Liver Disease Diagnosis and Treatment (18 papers). Asako Murayama is often cited by papers focused on Hepatitis C virus research (38 papers), Hepatitis B Virus Studies (37 papers) and Liver Disease Diagnosis and Treatment (18 papers). Asako Murayama collaborates with scholars based in Japan, United States and France. Asako Murayama's co-authors include Takaji Wakita, Takanobu Kato, Tomoko Date, Daisuke Akazawa, Akio Nomoto, Shusuke Kuge, Kenichi Morikawa, Takahiro Masaki, Tetsuro Suzuki and Ryosuke Suzuki and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Asako Murayama

49 papers receiving 1.6k citations

Peers

Asako Murayama

HEPAT

EPIDE

RNMI

Margarita Zayas Germany

George Koutsoudakis Germany

King-Song Jeng Taiwan

Wang‐Shick Ryu South Korea

Mami Matsuda Japan

Lih‐Hwa Hwang Taiwan

Mohsan Saeed United States

Romain Parent France

Yasuo Ariumi Japan

Sandrine Duvet France

Margarita Zayas Germany

Asako Murayama

1.4k ×1.4

HEPAT

1.1k ×1.3

EPIDE

549 ×1.1

142 ×0.8

RNMI

282 ×1.9

Citations per year, relative to Asako Murayama Asako Murayama (= 1×) peers Margarita Zayas

Countries citing papers authored by Asako Murayama

Since Specialization

Citations

This map shows the geographic impact of Asako Murayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asako Murayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asako Murayama more than expected).

Fields of papers citing papers by Asako Murayama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asako Murayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asako Murayama. The network helps show where Asako Murayama may publish in the future.

Co-authorship network of co-authors of Asako Murayama

This figure shows the co-authorship network connecting the top 25 collaborators of Asako Murayama. A scholar is included among the top collaborators of Asako Murayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asako Murayama. Asako Murayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murayama, Asako, N. Yamada, Masaaki Toyama, et al.. (2025). A synonymous mutation in the preS2 region enhances production of infectious hepatitis B virus. Virology. 612. 110692–110692. 1 indexed citations

Murayama, Asako, N. Yamada, Hussein Hassan Aly, et al.. (2024). Exploring the tolerable region for HiBiT tag insertion in the hepatitis B virus genome. mSphere. 9(10). e0051824–e0051824. 2 indexed citations

Momose, Haruka, Asako Murayama, N. Yamada, et al.. (2023). Performance evaluation of in vitro diagnostic kits for hepatitis B virus infection using the regional reference panel of Japan. Virology Journal. 20(1). 93–93. 6 indexed citations

Murayama, Asako, Megumi Murata, Tomoko Kiyohara, et al.. (2022). Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen. Nature Communications. 13(1). 5207–5207. 17 indexed citations

Murayama, Asako, Haruka Momose, N. Yamada, et al.. (2022). Performance Evaluation of In Vitro Screening and Diagnostic Kits for Hepatitis C Virus Infection. Frontiers in Cellular and Infection Microbiology. 11. 793472–793472. 2 indexed citations

Sugiyama, Masaya, Masataka Tsuge, Kento Fukano, et al.. (2022). The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro. PLoS Pathogens. 18(3). e1009983–e1009983. 15 indexed citations

Honda, Takashi, N. Yamada, Asako Murayama, et al.. (2021). Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure. Cellular and Molecular Gastroenterology and Hepatology. 12(5). 1583–1598. 7 indexed citations

Murayama, Asako & Takanobu Kato. (2021). Inhibition of hepatitis C virus by vitamin D. Vitamins and hormones. 117. 227–238. 5 indexed citations

Doi, Akira, Hayato Hikita, Yugo Kai, et al.. (2019). Combinations of two drugs among NS3/4A inhibitors, NS5B inhibitors and non-selective antiviral agents are effective for hepatitis C virus with NS5A-P32 deletion in humanized-liver mice. Journal of Gastroenterology. 54(5). 449–458. 6 indexed citations

10.

Shiina, Masaaki, N. Yamada, Ryuichi Sugiyama, et al.. (2019). Hepatitis B Virus Genotype-Dependent Vulnerability of Infected Cells to Immune Reaction in the Early Phase of Infection. Frontiers in Microbiology. 10. 2427–2427.

11.

Murayama, Asako, Haruka Momose, N. Yamada, et al.. (2019). Evaluation of in vitro screening and diagnostic kits for hepatitis B virus infection. Journal of Clinical Virology. 117. 37–42. 12 indexed citations

12.

Kato, Takanobu, Asako Murayama, & Takaji Wakita. (2018). Establishment of Replication-Competent HCV Strain with Minimum Modifications. Methods in molecular biology. 1911. 73–83. 1 indexed citations

13.

Aly, Hussein Hassan, Koichi Watashi, Asako Murayama, et al.. (2018). IL-1β/ATF3-mediated induction of Ski2 expression enhances hepatitis B virus x mRNA degradation. Biochemical and Biophysical Research Communications. 503(3). 1854–1860. 11 indexed citations

14.

Sung, Pil Soo, Asako Murayama, Wonseok Kang, et al.. (2014). Hepatitis C Virus Entry Is Impaired by Claudin-1 Downregulation in Diacylglycerol Acyltransferase-1-Deficient Cells. Journal of Virology. 88(16). 9233–9244. 26 indexed citations

15.

Matsumura, Takuya, Takanobu Kato, Megumi Tasaka‐Fujita, et al.. (2012). 25-hydroxyvitamin D3 suppresses hepatitis C virus production. Hepatology. 56(4). 1231–1239. 64 indexed citations

16.

Masaki, Takahiro, Asako Murayama, Tsubasa Munakata, et al.. (2011). Development of recombinant hepatitis C virus with NS5A from strains of genotypes 1 and 2. Biochemical and Biophysical Research Communications. 410(3). 404–409. 6 indexed citations

17.

Akazawa, Daisuke, Tomoko Date, Kenichi Morikawa, et al.. (2008). Characterization of infectious hepatitis C virus from liver-derived cell lines. Biochemical and Biophysical Research Communications. 377(3). 747–751. 9 indexed citations

18.

Date, Tomoko, Michiko Miyamoto, Takanobu Kato, et al.. (2007). An infectious and selectable full‐length replicon system with hepatitis C virus JFH‐1 strain. Hepatology Research. 37(6). 433–443. 21 indexed citations

19.

Morikawa, Kenichi, Zijiang Zhao, Tomoko Date, et al.. (2007). The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles. Journal of Medical Virology. 79(6). 714–723. 54 indexed citations

20.

Kato, Takanobu, Tomoko Date, Asako Murayama, et al.. (2006). Cell culture and infection system for hepatitis C virus. Nature Protocols. 1(5). 2334–2339. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact